TY - JOUR T1 - The plasmacytoid dendritic cell: a cell at the cross-roads in asthma JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/09031936.00203412 SP - erj02034-2012 AU - Jason P. Lynch AU - Stuart B. Mazzone AU - Matthew J. Rogers AU - Jaisy J. Arikkatt AU - Zhixuan Loh AU - Antonia L. Pritchard AU - John W. Upham AU - Simon Phipps Y1 - 2013/01/01 UR - http://erj.ersjournals.com/content/early/2013/02/21/09031936.00203412.abstract N2 - The onset, progression and exacerbations of asthma are frequently associated with virus infections of the lower respiratory tract. An emerging paradigm suggests that this relationship may be underpinned by a defect in the host's antiviral response, typified by the impaired production of type I and type III IFNs. The failure to control viral burden likely causes damage to the lung architecture and contributes to an aberrant immune response, which together, compromise lung function. Although a relatively rare cell type, the plasmacytoid dendritic cell dedicates much of its transcriptome to the synthesis of IFNs and is pre-armed with virus-sensing pattern recognition receptors. Thus, pDCs are specialised to ensure early viral detection and the rapid induction of the antiviral state to block viral replication and spread. In addition, pDC can also limit immunopathology, and promote peripheral tolerance to prevent allergic sensitisation to harmless antigens, possibly through the induction of regulatory T cells. Thus, this enigmatic cell may lie at an important intersection; orchestrating the immediate phase of antiviral immunity to effect viral clearance while regulating tolerance. Here we review the evidence to support the hypothesis that a primary defect in pDC function may underlie the development of asthma. ER -